Komo
-
Market Insight
Komo Announces 10:1 Consolidation
Komo Plant Based Foods Inc. (CSE: YUM) (OTCQB: KOMOF) (FSE: 9HB0) ( the “Company”, “Komo”), a premium plant‐based food company,…
Read More » -
Market Insight
Komo Plant Based Foods Reaches 400 Distribution Points with Addition of 11 Grocery Chains in Eastern Canada
Bristol Myers Squibb (NYSE: BMY) today announced results from the Phase 3 CheckMate -76K trial, in which Opdivo (nivolumab) as…
Read More » -
Market Insight
Komo Plant Based Food to be distributed by Coop Alentour
“Trodelvy has already changed the treatment landscape in second-line metastatic triple-negative breast cancer and pre-treated metastatic urothelial cancer, and today’s…
Read More » -
Market Insight
Komo closes $593,875 private placement
– Label expansion would make AbbVie the only company to offer two preventive treatments for those with chronic migraine, atogepant…
Read More » -
Market Insight
Komo Plant Based Foods Increases Distribution Through Freshspoke
– Label expansion would make AbbVie the only company to offer two preventive treatments for those with chronic migraine, atogepant…
Read More » -
Market Insight
Komo Plant Based Foods Announces Non-Brokered Private Placement
Komo Plant Based Foods Inc. (CSE: YUM) (OTCQB: KOMOF) (FSE: 9HB) (“Komo” or the “Company”) is pleased to announce a…
Read More » -
Market Insight
Komo Plant Based Appoints CEO White As Director
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) lifted the partial clinical hold…
Read More » -
Market Insight
Komo Plant-Based Foods (CSE:YUM) Investor Overview
Overview In 2021, the plant-based food market was worth an impressive US$7 billion, up 27 percent year over year and…
Read More »
